Hendrix Genetics, a leading multi-species animal genetics company, and NPM Capital, a subsidiary of family owned SHV Holdings, have signed a Memorandum of Understanding for NPM to become a minority shareholder in Hendrix Genetics via the issuing of new shares. Existing shareholders are the Hendrix family, Management and Sofiprotéol. 


Completion of the transaction is expected mid-year. The Hendrix family will remain the majority and controlling shareholder and the company will continue to conduct its business under current corporate governance and with the existing management team, strategy and structure. The transaction is subject to customary notification and approval requirements.